Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07325578Not ApplicableRecruiting

U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures

Role: collaborator

NCT06376682Not ApplicableCompleted

EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy

Role: collaborator

NCT05057975Not ApplicableCompleted

Validation of an Integrated Digital Solution (SUNrise®) Versus Polysomnography for Obstructive Sleep Apnea Diagnosis

Role: collaborator

NCT05974735Unknown

Adaptability to Stress of Healthcare Workers in the 8th Arrondissement

Role: collaborator

NCT03144570Completed

EURopean Study on Encephalitis in Intensive CAre

Role: lead

NCT04141176Not ApplicableCompleted

Obstructive Sleep Apnea Syndrome: Evaluation of the Efficacy of Sleepinnov© (Spiri+) Continuous Positive Airway Pressure Device

Role: collaborator

All 6 trials loaded